A simplified bi-monthly regimen with leucovorin (LV) and 5-Fluorouracil (5FU) for metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Tournigand, C
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles-Amar, V
Maindrault-Goebel, F
Lotz, JP
Molitor, JL
机构：
[1] Hop St Antoine, GERCOR, F-75571 Paris, France
[2] Hop Tenon, F-75970 Paris, France
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
189
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [22] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
    Cavanna, Luigi
    Artioli, Fabrizio
    Codignola, Claudio
    Lazzaro, Antonio
    Rizzi, Anna
    Gamboni, Alessandro
    Rota, Luigina
    Rodino, Carmelina
    Boni, Fabrizio
    Iop, Aldo
    Zaniboni, Alberto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 371 - 375
  • [23] CONTINUOUS INFUSION (CI) OF 5-FLUOROURACIL (5FU) AND CISPLATIN (DDP) FOR METASTATIC COLORECTAL-CANCER (MCRC) AND OTHER GASTROINTESTINAL MALIGNANCIES
    MADAJEWICZ, S
    BURK, M
    DAINER, P
    FIORE, J
    JOHNSON, H
    OSTROW, S
    SCHUBACH, W
    VIOLA, M
    KENNEDY, D
    VITKUN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 201 - 201
  • [24] Phase II study of oxaliplatin (OHP) and protracted 5-fluorouracil (5FU) infusion in pretreated metastatic colorectal cancer (MCRC) patients
    Mini, E
    Pinto, C
    Angelelli, B
    Dentico, P
    Piana, E
    Nobili, S
    Gentile, AL
    Scicolone, S
    Mazzei, T
    Martoni, A
    ANNALS OF ONCOLOGY, 2000, 11 : 73 - 73
  • [25] Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).
    Modest, Dominik Paul
    Karthaus, Meinolf
    Fruehauf, Stefan
    Graeven, Ullrich
    Mueller, Lothar
    Koenig, Alexander
    Von Weikersthal, Ludwig Fischer
    Caca, Karel
    Kretzschmar, Albrecht
    Goekkurt, Eray
    Haas, Siegfried
    Kurreck, Annika
    Stahler, Arndt
    Heinemann, Volker
    Held, Swantje
    Jarosch, Armin
    Horst, David
    Kasper, Stefan
    Stintzing, Sebastian
    Trarbach, Tanja
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Cost-effectiveness analysis of pharmacokinetic-guided (PK) 5-fluorouracil (5FU) when combined with leucovorin and oxaliplatin (FOLFOX) chemotherapy for metastatic colorectal cancer (mCRC)
    Goldstein, Daniel A.
    Chen, Qiushi
    Howard, David H.
    Lipscomb, Joseph
    Ayer, Turgay
    Harvey, Donald
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)
    Punt, CJA
    Keizer, HJ
    Douma, J
    Schüller, J
    Skovsgaard, T
    ten Napel, CHH
    Lochs, H
    Muller, EW
    Russell, L
    Wagener, DJT
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [28] LEUCOVORIN (LV) POTENTIATION OF 5-FLUOROURACIL(FU) EFFICIENCY AND POTENCY
    BRUCKNER, HW
    OHNUMA, T
    HART, R
    JAFFREY, I
    SPIEGELMAN, M
    AMBINDER, E
    STORCH, JA
    WILFINGER, C
    GOLDBERG, J
    BILLER, H
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 111 - 111
  • [29] Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
    Siveke, J. T.
    Chen, L-T
    Von Hoff, D. D.
    Li, C-P
    Wang-Gillam, A.
    Bodoky, G.
    Dean, A.
    Shan, Y-S
    Jameson, G.
    Macarulla, T.
    Lee, K-H
    Cunningham, D.
    Blanc, J-F
    Hubner, R. A.
    Chiu, C-F
    Schwartsmann, G.
    Braiteh, F.
    Moyo, V.
    Belanger, B.
    Bayever, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 170 - 170
  • [30] Addition of oxaliplatin (Eloxatine(R), LOHP) to the same leucovorin (LV) and 5 fluorouracil (5fU) bimonthly regimens after progression in patients (pts) with metastatic colorectal cancer (MCRC): Preliminary report
    Andre, T
    Bensmaine, MA
    Louvet, C
    Lucas, V
    Beerblock, K
    Desseigne, F
    Francois, E
    Merrouche, Y
    Bouche, O
    Morvan, F
    Carola, E
    deGramont, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 738 - 738
12345